Clinical trial
Treatment of Hepatocellular Carcinoma (HCC)by Selective Traditional Chemoembolization(TACE)Versus Selective TACE Via Microspheres Loaded With Doxorubicin: a Multicentre,Randomized,Open Label,Controlled Study.
NCT00936689 is registered in ClinicalTrials.gov with Rita Golfieri as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Treatment of Hepatocellular Carcinoma (HCC)by Selective Traditional Chemoembolization(TACE)Versus Selective TACE Via Microspheres Loaded With Doxorubicin: a Multicentre,Randomized,Open Label,Controlled Study.
- Lead sponsor
- Rita Golfieri
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- March 31, 2008
- Completion date
- December 31, 2012
- Enrollment
- 178 (actual)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.